Ito H, Morizet J, Coulombel L, Stanislawski M
Laboratoire d'Immunologie, UPR 278, CNRS, Villejuif, France.
Bone Marrow Transplant. 1990 Dec;6(6):395-8.
We have shown in a previous paper that an antibody-enzyme immunotoxin (eIT) constructed by chemically coupling the 097 monoclonal antibody to glucose oxidase and to lactoperoxidase (097 eIT) effectively eliminated T cells of human peripheral blood origin and killed cultured human thymoma cells. Here we tested its effectiveness against T cells present in human bone marrow cell suspensions contaminated by large numbers of erythrocytes. The T cell-depleting capacity of the 097 eIT was assessed by means of four different assay methods, three of which gave concordant results and indicated an effective depletion comparable in efficiency to published work. For example, by limiting dilution analysis assay of IL-2-producing T cells we found approximately 3 logs of T cell depletion. The growth of bone marrow stem cells (CFU-GM, CFU-E and BFU-E) was not affected by treatment with the 097 conjugates.
我们在之前的一篇论文中表明,通过将097单克隆抗体与葡萄糖氧化酶和乳过氧化物酶化学偶联构建的抗体 - 酶免疫毒素(eIT,即097 eIT)可有效清除人外周血来源的T细胞,并杀死培养的人胸腺瘤细胞。在此,我们测试了其对存在于被大量红细胞污染的人骨髓细胞悬液中的T细胞的有效性。通过四种不同的检测方法评估了097 eIT的T细胞耗竭能力,其中三种方法得出了一致的结果,表明其有效耗竭效率与已发表的研究相当。例如,通过对产生白细胞介素 - 2的T细胞进行有限稀释分析检测,我们发现T细胞耗竭约为3个对数级。097偶联物处理并未影响骨髓干细胞(CFU - GM、CFU - E和BFU - E)的生长。